A quality of life comparison in cyclosporine- and tacrolimus-treated renal transplant recipients across Canada.
Conclusion: QoL among Canadian renal transplant recipients receiving cyclosporine or tacrolimus is similar. Although Canadian recipients prefer tacrolimus, CNI type does not significantly affect their QoL.
PMID: 20383867 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)